.jpg)
Digital Archive
This story is part of our historical records. While preserved for reference, some details and facts may have evolved since its original publication 6 months ago.
Veru to Present Three Presentations at the 2022 American Society for Clinical Oncology Annual Meeting on June 3-7
MIAMI, May 31, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that the Company will be presenting three presentations at the 2022 American Society of Clinical Oncology Annual Meeting which will...
S
Sangri Today Spotlight
BREAKING
Sangri Today
4 years ago
Veru to Present Three Presentations at the 2022 American Society for Clinical Oncology Annual Meeting on June 3-7
MIAMI, May 31, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that the Company will be presenting three presentations at the 2022 American Society of Clinical Oncology Annual Meeting which will...
Full Story: https://www.sangritoday.com/spotlight/veru-to-present-three-presentations-at-the-2022-american-society-for-clinical-oncology-annual-meeting-on-june-3-7
MIAMI, May 31, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that the Company will be presenting three presentations at the 2022 American Society of Clinical Oncology Annual Meeting which will be held in Chicago, IL from June 3-7, 2022.
history
This is an archived post. The information provided may be outdated.
